(Reuters) - Vertex Pharmaceuticals raised its annualrevenueforecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments. The drugmaker now expects ...
Some results have been hidden because they may be inaccessible to you